Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
CerFlux offers personalized medicine technology for matching treatments to tumors
Innovative Solution
CerFlux offers personalized medicine technology for matching treatments to tumors that aim to improve outcomes and quality of life while reducing the time, the pain, and the cost of cancer treatment.
Investment Funding
Last Funding Stage
Grant
Total Funding Amount
375.K
Last Funding Amount
275.K
Last Funding Date
03-08-2023
Lead Investors
National Science Foundation, Innovate Alabama
Revenue
$1M to $10M
People
Founders
Karim Budhwani
About
CerFlux offers personalized medicine technology for matching treatments to tumors that aim to improve outcomes and quality of life while reducing the time, the pain, and the cost of cancer treatment.
Something missing or incorrect on this page? Help us enrich this information
